Melatonin receptor-mediated protection against myocardial ischemia/reperfusion injury: Role of SIRT1

Journal of Pineal Research

Volumn 57, Issue 2, 2014, Pages 228-238

  Yu, Liming ^a   Sun, Yang ^a   Cheng, Liang ^a   Jin, Zhenxiao ^a   Yang, Yang ^a   Zhai, Mengen ^a   Pei, Haifeng ^a,b   Wang, Xiaowu ^a   Zhang, Haifeng ^c   Meng, Qiang ^a   Zhang, Yu ^a   Yu, Shiqiang ^a   Duan, Weixun ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b CHENGDU MILITARY GENERAL HOSPITAL   (China)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

cardioprotection; ischemia reperfusion; melatonin; melatonin receptor; oxidative stress; SIRT1 signaling

Indexed keywords

CASPASE 3; CREATINE KINASE; ENZYME INHIBITOR; EX527; LACTATE DEHYDROGENASE; LUZINDOLE; MALONALDEHYDE; MELATONIN; MELATONIN RECEPTOR; PROTEIN BAX; PROTEIN BCL 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SILENT INFORMATION REGULATOR PROTEIN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; 6-CHLORO-2,3,4,9-TETRAHYDRO-1H-CARBAZOLE-1-CARBOXAMIDE; CARBAZOLE DERIVATIVE; SIRT1 PROTEIN, RAT; SIRTUIN 1; TRYPTAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME RELEASE; EXPERIMENTAL MYOCARDIAL ISCHEMIA; HEART FUNCTION; HEART INFARCTION SIZE; HEART PROTECTION; LACTATE DEHYDROGENASE BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; HEART MUSCLE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CARBAZOLES; CASPASE 3; L-LACTATE DEHYDROGENASE; MALE; MELATONIN; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, MELATONIN; SIGNAL TRANSDUCTION; SIRTUIN 1; SUPEROXIDE DISMUTASE; TRYPTAMINES;

EID: 84925835400     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/jpi.12161     Document Type: Article

References (42)

1. Matsumura K, Jeremy RW, Schaper J, et al. Progression of myocardial necrosis during reperfusion of ischemic myocardium. Circulation 1998; 97: 795-804. (Pubitemid 28135343)
2. Zweier JL, Talukder MA,. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006; 70: 181-190.
3. Reiter RJ, Tan DX,. Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart. Cardiovasc Res 2003; 58: 10-19. (Pubitemid 36351618)
4. Tengattini S, Reiter RJ, Tan DX, et al. Cardiovascular diseases: protective effects of melatonin. J Pineal Res 2008; 44: 16-25. (Pubitemid 350231106)
5. Sahna E, Parlakpinar H, Turkoz Y, et al. Protective effects of melatonin on myocardial ischemia/reperfusion induced infarct size and oxidative changes. Physiol Res 2005; 54: 491-495. (Pubitemid 41578671)
6. Yang Y, Duan W, Jin Z, et al. JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury. J Pineal Res 2013; 55: 275-286.
7. Brunet A, Sweeney LB, Sturgill JF, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 2004; 303: 2011-2015. (Pubitemid 38393275)
8. Daitoku H, Hatta M, Matsuzaki H, et al. Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity. Proc Natl Acad Sci USA 2004; 101: 10042-10047. (Pubitemid 38891191)
9. Hsu CP, Zhai P, Yamamoto T, et al. Silent information regulator 1 protects the heart from ischemia/reperfusion. Circulation 2010; 122: 2170-2182.
10. Tong C, Morrison A, Mattison S, et al. Impaired SIRT1 nucleocytoplasmic shuttling in the senescent heart during ischemic stress. FASEB J 2013; 27: 4332-4342.
11. Chang HM, Wu UI, Lan CT,. Melatonin preserves longevity protein (sirtuin 1) expression in the hippocampus of total sleep-deprived rats. J Pineal Res 2009; 47: 211-220.
12. Tajes M, Gutierrez-Cuesta J, Ortuno-Sahagun D, et al. Anti-aging properties of melatonin in an in vitro murine senescence model: involvement of the sirtuin 1 pathway. J Pineal Res 2009; 47: 228-237.
13. Galano A, Tan DX, Reiter RJ,. Melatonin as a natural ally against oxidative stress: a physicochemical examination. J Pineal Res 2011; 51: 1-16.
14. Galano A, Tan DX, Reiter RJ,. On the free radical scavenging activities of melatonin's metabolites, AFMK and AMK. J Pineal Res 2013; 54: 245-257.
15. Tan DX, Chen LD, Poeggeler B, et al. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1993; 1: 57-60.
16. Zhang H, Squadrito GL, Pryor WA,. The reaction of melatonin with peroxynitrite: formation of melatonin radical cation and absence of stable nitrated products. Biochem Biophys Res Commun 1998; 251: 83-87. (Pubitemid 28498067)
17. Rezzani R, Rodella LF, Bonomini F, et al. Beneficial effects of melatonin in protecting against cyclosporine A-induced cardiotoxicity are receptor mediated. J Pineal Res 2006; 41: 288-295. (Pubitemid 44337727)
18. Lochner A, Genade S, Davids A, et al. Short- and long-term effects of melatonin on myocardial post-ischemic recovery. J Pineal Res 2006; 40: 56-63.
19. Yang Y, Duan W, Lin Y, et al. SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free Radic Biol Med 2013; 65: 667-679.
20. Tao L, Wang Y, Gao E, et al. Adiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction. Circ Res 2010; 106: 409-417.
21. Su H, Ji L, Xing W, et al. Acute hyperglycaemia enhances oxidative stress and aggravates myocardial ischaemia/reperfusion injury: role of thioredoxin-interacting protein. J Cell Mol Med 2013; 17: 181-191.
22. Tan DX, Hardeland R, Manchester LC, et al. Cyclic-3-hydroxymelatonin (C3HOM), a potent antioxidant, scavenges free radicals and suppresses oxidative reactions. Curr Med Chem 2014; 21: 1557-1565.
23. Galano A, Tan DX, Reiter RJ,. Cyclic 3-hydroxymelatonin: a key metabolite enhancing the peroxyl radical scavenging activity of melatonin. RSC Adv 2014; 4: 5220-5227.
24. Szarszoi O, Asemu G, Vanecek J, et al. Effects of melatonin on ischemia and reperfusion injury of the rat heart. Cardiovasc Drugs Ther 2001; 15: 251-257. (Pubitemid 33010608)
25. Lee YM, Chen HR, Hsiao G, et al. Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo. J Pineal Res 2002; 33: 72-80. (Pubitemid 34913483)
26. Sahna E, Olmez E, Acet A,. Effects of physiological and pharmacological concentrations of melatonin on ischemia-reperfusion arrhythmias in rats: can the incidence of sudden cardiac death be reduced? J Pineal Res 2002; 32: 194-198. (Pubitemid 34309887)
27. Sahna E, Parlakpinar H, Ozer MK, et al. Melatonin protects against myocardial doxorubicin toxicity in rats: role of physiological concentrations. J Pineal Res 2003; 35: 257-261. (Pubitemid 37338859)
28. Yang Y, Duan W, Li Y, et al. Novel role of silent information regulator 1 in myocardial ischemia. Circulation 2013; 128: 2232-2240.
29. Gutierrez-Cuesta J, Tajes M, Jimenez A, et al. Evaluation of potential pro-survival pathways regulated by melatonin in a murine senescence model. J Pineal Res 2008; 45: 497-505.
30. Jung-Hynes B, Schmit TL, Reagan-Shaw SR, et al. Melatonin, a novel Sirt1 inhibitor, imparts antiproliferative effects against prostate cancer in vitro in culture and in vivo in TRAMP model. J Pineal Res 2011; 50: 140-149.
31. Cheng Y, Cai L, Jiang P, et al. SIRT1 inhibition by melatonin exerts antitumor activity in human osteosarcoma cells. Eur J Pharmacol 2013; 715: 219-229.
32. Lim HD, Kim YS, Ko SH, et al. Cytoprotective and anti-inflammatory effects of melatonin in hydrogen peroxide-stimulated CHON-001 human chondrocyte cell line and rabbit model of osteoarthritis via the SIRT1 pathway. J Pineal Res 2012; 53: 225-237.
33. Vinciguerra M, Santini MP, Martinez C, et al. mIGF-1/JNK1/SirT1 signaling confers protection against oxidative stress in the heart. Aging Cell 2012; 11: 139-149.
34. Braidy N, Guillemin GJ, Mansour H, et al. Age related changes in NAD+ metabolism oxidative stress and Sirt1 activity in wistar rats. PLoS ONE 2011; 6: e19194.
35. Dubocovich ML, Masana MI, Iacob S, et al. Melatonin receptor antagonists that differentiate between the human Mel1a and Mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn Schmiedebergs Arch Pharmacol 1997; 355: 365-375. (Pubitemid 27117595)
36. Reiter RJ, Tan DX, Gitto E, et al. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. Pol J Pharmacol 2004; 56: 159-170. (Pubitemid 38931382)
37. Karbownik M, Reiter RJ,. Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation. Proc Soc Exp Biol Med 2000; 225: 9-22.
38. Choi SI, Dadakhujaev S, Ryu H, et al. Melatonin protects against oxidative stress in granular corneal dystrophy type 2 corneal fibroblasts by mechanisms that involve membrane melatonin receptors. J Pineal Res 2011; 51: 94-103.
39. Wang FW, Wang Z, Zhang YM, et al. Protective effect of melatonin on bone marrow mesenchymal stem cells against hydrogen peroxide-induced apoptosis in vitro. J Cell Biochem 2013; 114: 2346-2355.
40. Rosen RB, Hu DN, Chen M, et al. Effects of melatonin and its receptor antagonist on retinal pigment epithelial cells against hydrogen peroxide damage. Mol Vis 2012; 18: 1640-1648.
41. Petit L, Lacroix I, de Coppet P, et al. Differential signaling of human Mel1a and Mel1b melatonin receptors through the cyclic guanosine 3'-5'-monophosphate pathway. Biochem Pharmacol 1999; 58: 633-639. (Pubitemid 29296883)
42. Fields TA, Casey PJ,. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem J 1997; 321 (Pt 3): 561-571. (Pubitemid 27084859)